373 related articles for article (PubMed ID: 20185808)
1. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
[TBL] [Abstract][Full Text] [Related]
4. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
[TBL] [Abstract][Full Text] [Related]
5. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
[TBL] [Abstract][Full Text] [Related]
6. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
7. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
Wojczynski MK; Glasser SP; Oberman A; Kabagambe EK; Hopkins PN; Tsai MY; Straka RJ; Ordovas JM; Arnett DK
Lipids Health Dis; 2011 Oct; 10():181. PubMed ID: 22008512
[TBL] [Abstract][Full Text] [Related]
8. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
[TBL] [Abstract][Full Text] [Related]
9. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
Sam S; Haffner S; Davidson MH; D'Agostino RB; Feinstein S; Kondos G; Perez A; Mazzone T
Diabetes; 2008 Aug; 57(8):2022-7. PubMed ID: 18469202
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis.
Mackey RH; Mora S; Bertoni AG; Wassel CL; Carnethon MR; Sibley CT; Goff DC
Diabetes Care; 2015 Apr; 38(4):628-36. PubMed ID: 25592196
[TBL] [Abstract][Full Text] [Related]
11. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.
Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
Am J Cardiol; 2002 Oct; 90(8A):71i-76i. PubMed ID: 12419483
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Magnetic Resonance-Based Metabolomics and Risk of CKD.
Geng TT; Chen JX; Lu Q; Wang PL; Xia PF; Zhu K; Li Y; Guo KQ; Yang K; Liao YF; Zhou YF; Liu G; Pan A
Am J Kidney Dis; 2024 Jan; 83(1):9-17. PubMed ID: 37678743
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein subclass abnormalities and incident hypertension in initially healthy women.
Paynter NP; Sesso HD; Conen D; Otvos JD; Mora S
Clin Chem; 2011 Aug; 57(8):1178-87. PubMed ID: 21700954
[TBL] [Abstract][Full Text] [Related]
16. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
Dullaart RP; de Vries R; Lefrandt JD
Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
[TBL] [Abstract][Full Text] [Related]
18. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
[TBL] [Abstract][Full Text] [Related]
19. NMR identifies atherogenic lipoprotein abnormalities in early diabetic nephropathy that are unrecognized by conventional analysis.
Al-Shahrouri HZ; Ramirez P; Fanti P; Abboud H; Lorenzo C; Haffner S
Clin Nephrol; 2010 Mar; 73(3):180-9. PubMed ID: 20178716
[TBL] [Abstract][Full Text] [Related]
20. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
